Jefferies Upgrades Insulet to Buy, Lowers Price Target to $240
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Matthew Taylor has upgraded Insulet (NASDAQ:PODD) from Hold to Buy, but lowered the price target from $260 to $240.
October 02, 2023 | 8:50 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Insulet (NASDAQ:PODD) has been upgraded to Buy from Hold by Jefferies, but the price target has been lowered from $260 to $240.
The upgrade to Buy indicates a positive outlook for Insulet's stock. However, the lowering of the price target may temper the positive impact slightly. Overall, the news is likely to have a positive impact on the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100